Research suggests that the available studies linked here do not directly investigate vitamin B12 as an intervention for homocysteine reduction; instead, the four studies cover tangential topics such as B12's potential role in modulating inflammatory gene expression in COVID-19 patients through epigenetic mechanisms, B12-sensing genetic switches in tuberculosis bacteria, DNA methylation and child growth, and a comparison of genetic analysis frameworks. While the epigenetic mechanisms explored in these studies — particularly around DNA methylation and methyl group availability — are biochemically related to the pathways through which B12 is known to influence homocysteine metabolism, none of the studies directly measure or report homocysteine levels as an outcome. The studies are a mix of laboratory-based and observational research, and their findings neither support nor refute claims about B12 supplementation for homocysteine reduction in a direct or clinically applicable way. Readers seeking evidence on this specific relationship would need to consult literature that explicitly examines B12 intervention and homocysteine as a primary endpoint.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Vitamin B12 attenuates leukocyte inflammatory signature in COVID-19 via methy... | Other | 2022 | Supports | 85 |
| <i>Mycobacterium tuberculosis</i>employs atypical and different classes of B<... | Other | 2023 | Neutral | 80 |
| DNA methylation at the suppressor of cytokine signaling 3 (<i>SOCS3</i>) gene... | Other | 2022 | Neutral | 75 |
| Investigative power of Genomic Informational Field Theory (GIFT) relative to ... | Other | 2024 | Neutral | 70 |